Assessing the second-hand effects of a new no-smoking policy in an acute mental health trust.

Aims and method To examine whether a new no-smoking policy in an in-patient mental health setting had any effects outside of smoking cessation. Our hypothesis stated that a forced smoking ban for in-patients may result in an increased susceptibility for clinical incidents, aggression and lower admission rates. All patients admitted to adult in-patient mental health services in Coventry and Warwickshire Partnership NHS Trust were included in the analysis. Data 6 months post-implementation of the smoking policy (1 July 2015 to 1 January 2016) were compared with the same period 1 year prior (1 July 2014 to 1 January 2015). Patient demographics, admission rates, ward occupancy, average lengths of stay, numbers of reported incidents and use of the Mental Health Act 1983 (MHA) were compared. Results We analysed 4223 admissions. We found a significantly increased number of admissions under the MHA (P = 0.007), a significantly greater number of reported smoking-related incidents (P < 0.001) and aggression-related incidents in the psychiatric intensive care unit (P < 0.001). However, we found no significant difference in capacity of in-patient wards (P = 0.39), admission length (P = 0.34) or total aggression-related incidents (P = 0.86). Clinical implications Although further comparisons over longer time periods are necessary, our results suggest that enforced smoking cessation on acutely unwell psychiatric patients admitted to the most restricted environments may have some negative effects. Nicotine replacement therapy should be offered to all patients to minimise the risk of clinical incident.

Fluoxetine treatment of selective mutism in pervasive developmental disorder.

We report the successful treatment of selective mutism in a child with pervasive developmental disorder (PDD). There are several studies and case reports in which Fluoxetine has been reported effective in diminishing adult social anxiety and increasing speech in public settings. The literature is much smaller for children. The efficacy of fluoxetine supports the argument that selective mutism is a developmental equivalent of social anxiety disorder. To our knowledge this is the first description of successful treatment when the selective mutism is complicated by PDD.

Elective mutism: A case study.

We report a case of persistent elective mutism in a young single woman. To our knowledge there has been no published study or case report of persistent elective mutism starting at the age of acquisition of language and persisting until she was 22.